NCT01076010
- Conditions
- Advanced Renal Cell Carcinoma
- Locations
-
- Site 185 Los Angeles, California, United States
- Site 184 Orlando, Florida, United States
- Site 182 Minneapolis, Minnesota, United States
- Site 186 New York, United States
Clinical trial condition
Advanced Renal Cell Carcinoma
Explore clinical trials studying Advanced Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
51 public trials
12 recruiting studies
Advanced Renal Cell Carcinoma trial results
NCT00853372
- Conditions
- Advanced Renal Cell Carcinoma
- Locations
-
Not specified
Completed
A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma
NCT01030783
- Conditions
- Advanced Renal Cell Carcinoma
- Locations
-
- Site 185 Los Angeles, California, United States
- Site 180 Gainesville, Florida, United States
- Site 184 Orlando, Florida, United States
- Site 182 Minneapolis, Minnesota, United States
NCT02143492
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +16 more
- Locations
-
- Englewood, Colorado, United States
- Marietta, Georgia, United States
- Woodbury, Minnesota, United States
- Rock Hill, North Carolina, United States
NCT00467025
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +14 more
- Locations
-
Not specified
NCT00422019
- Conditions
- Advanced Renal Cell Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
Not specified
NCT00425035
- Conditions
- Advanced Renal Cell Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
Not specified
NCT00494091
- Conditions
- Advanced Renal Cell Carcinoma
- Locations
-
- Pfizer Investigational Site Nanjing, Jiangsu, China
- Pfizer Investigational Site Beijing, China
- Pfizer Investigational Site Beijing, China
- Pfizer Investigational Site Beijing, China
NCT00486538
- Conditions
- Advanced Renal Cell Carcinoma
- Locations
-
- Site Reference ID/Investigator# 7193 Sacramento, California, United States
- Site Reference ID/Investigator# 5243 Washington D.C., District of Columbia, United States
- Site Reference ID/Investigator# 5384 Chicago, Illinois, United States
- Site Reference ID/Investigator# 11662 Boston, Massachusetts, United States
NCT00197860
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +14 more
- Locations
-
- Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark